Investing.com - Abeona Therapeutics (NASDAQ:ABEO) reported on Monday third quarter earnings that missed analysts' forecasts and revenue that was in line with expectations.
Abeona Therapeutics announced earnings per share of $-1.4800 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-1.4700 on revenue of $0.
Abeona Therapeutics shares are down 45% from the beginning of the year, still down 82.98% from its 52 week high of $23.55 set on November 15, 2021.
Abeona Therapeutics shares lost 8.70% in intra-day trade following the report.
Abeona Therapeutics follows other major Healthcare sector earnings this month
Abeona Therapeutics's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar